Breast cancer patients treated with alpelisib have elevated rates of high blood sugar

[News]

New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with breast cancer who are treated with the oral medication alpelisib.

More... (https://www.news-medical.net/news/20230925/Breast-cancer-patients-treated-with-alpelisib-have-elevated-rates-of-high-blood-sugar.aspx)